
Chemiloids Life Sciences Private Limited
Produces herbal products since 2014, based in Vijayawada, Andhra Pradesh.
Produces herbal products since 2014, based in Vijayawada, Andhra Pradesh.
Chemiloids Life Sciences Private Limited (CLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 August 2014 and has a history of Ten years and seven months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹17.50 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkata Gokaraju, Gokaraju Raju, and Ganga Gokaraju serve as directors at the Company.
Krishna, Andhra Pradesh, India
+91-XXXXXXXXXX
U24100AP2014PTC095114
095114
Private Limited Indian Non-Government Company
21 Aug 2014
30 Sep 2024
31 Mar 2024
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkata Gokaraju ![]() | Director | 21-Aug-2014 | Current |
Gokaraju Raju ![]() | Director | 21-Aug-2014 | Current |
Ganga Gokaraju ![]() | Director | 01-Apr-2015 | Current |
Chemiloids Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 19.15% increase. The company also saw a substantial improvement in profitability, with a 122.5% increase in profit. The company's net worth Soared by an impressive increase of 54.8%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Chemiloids Life Sciences had a promoter holding of 73.33% and a public holding of 26.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gokaraju Raju and Ganga Gokaraju are mutual person
Venkata Gokaraju, Gokaraju Raju and 1 more are mutual person
Venkata Gokaraju and Ganga Gokaraju are mutual person
Venkata Gokaraju, Gokaraju Raju and 1 more are mutual person
Venkata Gokaraju and Ganga Gokaraju are mutual person
Venkata Gokaraju, Gokaraju Raju and 1 more are mutual person
₹17.50 Cr
₹6.00 Cr
Date | Lender | Amount | Status |
---|---|---|---|
16 Nov 2020 | Axis Bank Limited | ₹17.50 Cr | Open |
09 Oct 2015 | Others | ₹6.00 Cr | Satisfied |
Chemiloids Life Sciences has a workforce of 211 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chemiloids Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemiloids Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chemiloids Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Chemiloids Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
A charge with Axis Bank Limited of Rs. 17.50 Cr registered on 16 Nov 2020 with Charge ID 100391907 was modified on 28 Jan 2022.
A charge registered on 09 Oct 2015 via Charge ID 10597354 with Others was fully satisfied on 30 Dec 2020.
A charge with Axis Bank Limited amounted to Rs. 17.50 Cr with Charge ID 100391907 was registered on 16 Nov 2020.
A charge with Others of Rs. 6.00 Cr registered on 09 Oct 2015 with Charge ID 10597354 was modified on 22 Apr 2019.
Chemiloids Life Sciences Private Limited was incorporated on 21 Aug 2014.
The authorized share capital of Chemiloids Life Sciences Private Limited is ₹ 6.00 Cr and paid-up capital is ₹ 6.00 Cr.
Currently 3 directors are associated with Chemiloids Life Sciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Chemiloids Life Sciences Private Limited is 40-15-14 Brindavan Colony, Labbipet India, Vijayawada, Andhra Pradesh, 520010.
The corporate identification number (CIN) of Chemiloids Life Sciences Private Limited is U24100AP2014PTC095114 and the company number is 095114 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Chemiloids Life Sciences Private Limited has risen by 19.15%.
As Per 2019 financial reports, 211 employees are currently employed by Chemiloids Life Sciences Private Limited.
The financial reports for the fiscal year 2019 indicates that The net worth of Chemiloids Life Sciences Private Limited has experienced an upsurge of 54.80%.
As per the financial statements for fiscal Year 2019, The total open charges for Chemiloids Life Sciences Private Limited amount to ₹ 17.50 Cr.
The most recent Balance Sheet for Chemiloids Life Sciences Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.